Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,633.85
2,523.73
2,851.04
2,319.21
2,155.96
1,690.70
1,695.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,633.85
2,523.73
2,851.04
2,319.21
2,155.96
1,690.70
1,695.50
Raw Material Cost
686.83
616.41
664.62
546.25
488.02
401.43
414.40
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.05
3.51
2.94
2.48
2.25
1.78
3.87
Selling and Distribution Expenses
927.88
962.16
1,021.19
820.31
919.87
788.52
810.22
Other Expenses
20.33
18.81
24.11
15.22
15.02
11.22
10.40
Total Expenditure (Excl Depreciation)
1,821.11
1,770.19
1,929.85
1,521.21
1,560.32
1,303.93
1,332.49
Operating Profit (PBDIT) excl Other Income
812.6999999999999
753.5
921.2
798
595.6
386.8
363
Other Income
66.12
83.42
61.13
57.35
52.76
64.46
31.46
Operating Profit (PBDIT)
978.30
946.39
1,069.66
929.36
729.15
515.34
459.59
Interest
3.05
3.51
2.94
2.48
2.25
1.78
3.87
Exceptional Items
1.88
11.44
-12.03
16.27
-325.66
-12.62
-210.16
Gross Profit (PBDT)
1,947.02
1,907.32
2,186.42
1,772.96
1,667.94
1,289.27
1,281.11
Depreciation
126.81
124.15
103.05
88.88
88.75
70.29
66.52
Profit Before Tax
850.32
830.17
951.64
854.28
312.49
430.65
179.05
Tax
85.82
87.18
61.34
96.19
91.73
69.60
53.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
735.19
706.95
847.23
703.26
206.63
358.96
124.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
735.19
706.95
847.23
703.26
206.63
358.96
124.47
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
12.15
8.89
11.36
34.40
-3.24
-12.42
-14.07
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
747.34
715.84
858.59
737.66
203.39
346.53
110.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,558.02
4,124.31
3,737.40
3,208.59
2,786.60
2,835.74
2,626.68
Earnings per share (EPS)
0.44
0.43
0.52
0.43
0.13
0.22
0.08
Diluted Earnings per share
0.44
0.43
0.52
0.43
0.13
0.22
0.08
Operating Profit Margin (Excl OI)
29.82%
29.27%
31.76%
33.77%
27.26%
22.51%
21.33%
Gross Profit Margin
37.1%
37.81%
36.99%
40.67%
18.61%
29.63%
14.48%
PAT Margin
27.91%
28.01%
29.72%
30.32%
9.58%
21.23%
7.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 4.36% vs -11.48% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 4.40% vs -16.63% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 5.70% vs -14.43% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -11.43% vs 20.69% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Anhui Anke Biotechnology (Group) Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,633.85
0
2,633.85
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,633.85
0
2,633.85
Raw Material Cost
686.83
0
686.83
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.05
0
3.05
Selling and Distribution Expenses
927.88
0
927.88
Other Expenses
20.33
0.00
20.33
Total Expenditure (Excl Depreciation)
1,821.11
0
1,821.11
Operating Profit (PBDIT) excl Other Income
812.74
0.00
812.74
Other Income
66.12
0
66.12
Operating Profit (PBDIT)
978.30
0
978.30
Interest
3.05
0
3.05
Exceptional Items
1.88
0
1.88
Gross Profit (PBDT)
1,947.02
0
1,947.02
Depreciation
126.81
0
126.81
Profit Before Tax
850.32
0
850.32
Tax
85.82
0
85.82
Provisions and contingencies
0
0
0.00
Profit After Tax
735.19
0
735.19
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
735.19
0
735.19
Share in Profit of Associates
0
0
0.00
Minority Interest
12.15
0
12.15
Other related items
0.00
0.00
0.00
Consolidated Net Profit
747.34
0
747.34
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,558.02
0
4,558.02
Earnings per share (EPS)
0.44
0
0.44
Diluted Earnings per share
0.44
0
0.44
Operating Profit Margin (Excl OI)
29.82%
0%
0.00
29.82%
Gross Profit Margin
37.10%
0%
0.00
37.10%
PAT Margin
27.91%
0%
0.00
27.91%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 263.38 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 4.36% vs -11.48% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 74.73 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 4.40% vs -16.63% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.22 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 5.70% vs -14.43% in Dec 2024
Annual - Interest
Interest 0.31 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -11.43% vs 20.69% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 29.82%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






